Scientists are exploring photocatalysis, using light to accelerate enzyme reactions in microbes for drug and chemical production.
Photobiocatalysis combines light energy with enzyme precision to assemble complex molecular structures.
Researchers have engineered microbes like Pichia pastoris and Escherichia coli to produce valuable compounds, including anti-cancer drugs and degradable plastics.
A team at the University of Illinois has engineered E. coli to produce non-natural olefins and reductases from glucose using blue light-activated enzymes.
Detailed Insights:
Photocatalysis involves using light, including ultraviolet radiation, to initiate chemical reactions, opening possibilities for enzyme engineering and drug discovery.
Light-activated enzymes convert light energy into chemical action, with light triggering rapid shape changes that activate the enzyme.
Scientists are repurposing natural enzymes through photobiocatalysis to produce novel medicinal products.
Researchers are exploring gene transfer from bacteria to plants to discover new paths for drug discovery, leveraging molecules from microbes to produce toxic defense molecules.
E. coli has been engineered to produce various products, including insulin, cost-effective proteins, pyridine dicarboxylate (a degradable plastic), styrene polymer, and precursors to anti-cancer drugs.
Combining photobiosynthesis with microbial bioreactors allows for large-scale chemical production, integrating light-driven reactions into cellular metabolism.
Scientific/Technical Concepts Involved:
Photocatalysis: Using light to initiate and accelerate chemical reactions.
Enzymes: Biological catalysts that speed up chemical reactions in living organisms.
Photobiocatalysis: Utilizing light energy and enzymes to produce complex structures.
Microbial bioreactor: A system using microorganisms to carry out specific chemical transformations.